22-26451986-ACG-A
Variant names:
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BS1_SupportingBS2
The NM_022081.6(HPS4):c.*1245_*1246delCG variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0129 in 149,082 control chromosomes in the GnomAD database, including 19 homozygotes. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Genomes: 𝑓 0.014 ( 19 hom., cov: 0)
Exomes 𝑓: 0.0061 ( 0 hom. )
Consequence
HPS4
NM_022081.6 3_prime_UTR
NM_022081.6 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.477
Genes affected
HPS4 (HGNC:15844): (HPS4 biogenesis of lysosomal organelles complex 3 subunit 2) This gene encodes a protein component of biogenesis of lysosome-related organelles complexes (BLOC). BLOC complexes are important for the formation of endosomal-lysosomal organelles such as melanosomes and platelet dense granules. Mutations in this gene result in subtype 4 of Hermansky-Pudlak syndrome, a form of albinism. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2012]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -5 ACMG points.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.0136 (1830/134766) while in subpopulation EAS AF = 0.0209 (94/4504). AF 95% confidence interval is 0.0175. There are 19 homozygotes in GnomAd4. There are 871 alleles in the male GnomAd4 subpopulation. Median coverage is 0. This position FAILED quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAd4 at 19 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HPS4 | NM_022081.6 | c.*1245_*1246delCG | 3_prime_UTR_variant | Exon 14 of 14 | ENST00000398145.7 | NP_071364.4 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0136 AC: 1829AN: 134686Hom.: 19 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
1829
AN:
134686
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00608 AC: 87AN: 14316Hom.: 0 AF XY: 0.00618 AC XY: 50AN XY: 8096 show subpopulations
GnomAD4 exome
AF:
AC:
87
AN:
14316
Hom.:
AF XY:
AC XY:
50
AN XY:
8096
Gnomad4 AFR exome
AF:
AC:
6
AN:
320
Gnomad4 AMR exome
AF:
AC:
7
AN:
944
Gnomad4 ASJ exome
AF:
AC:
3
AN:
316
Gnomad4 EAS exome
AF:
AC:
4
AN:
304
Gnomad4 SAS exome
AF:
AC:
11
AN:
2416
Gnomad4 FIN exome
AF:
AC:
2
AN:
464
Gnomad4 NFE exome
AF:
AC:
51
AN:
8948
Gnomad4 Remaining exome
AF:
AC:
3
AN:
560
Heterozygous variant carriers
0
6
13
19
26
32
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0136 AC: 1830AN: 134766Hom.: 19 Cov.: 0 AF XY: 0.0134 AC XY: 871AN XY: 65068 show subpopulations
GnomAD4 genome
AF:
AC:
1830
AN:
134766
Hom.:
Cov.:
0
AF XY:
AC XY:
871
AN XY:
65068
Gnomad4 AFR
AF:
AC:
0.0121029
AN:
0.0121029
Gnomad4 AMR
AF:
AC:
0.0137118
AN:
0.0137118
Gnomad4 ASJ
AF:
AC:
0.0172518
AN:
0.0172518
Gnomad4 EAS
AF:
AC:
0.0208703
AN:
0.0208703
Gnomad4 SAS
AF:
AC:
0.00664697
AN:
0.00664697
Gnomad4 FIN
AF:
AC:
0.0108646
AN:
0.0108646
Gnomad4 NFE
AF:
AC:
0.0144788
AN:
0.0144788
Gnomad4 OTH
AF:
AC:
0.0180659
AN:
0.0180659
Heterozygous variant carriers
0
67
133
200
266
333
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Hermansky-Pudlak syndrome Uncertain:2
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Uncertain:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Mutation Taster
=100/0
polymorphism
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at